In this webinar we welcome paediatric oncologist at the Children's Hospital Westmead and clinical lead for the upcoming Australian TiNT MEK Inhibitor Clinical Trial, Dr Geoff McCowage.
This a unique opportunity to hear directly from the person who is responsible for ensuring this trial is made available to Australian and New Zealand patients and will cover the following topics:
- What is a MEK inhibitor
- How do MEK inhibitors work in NF
- Prior research into MEK Inhibitors
- Timing and eligibility criteria for the Australian TiNT clinical Trial